Imagia Canexia Health puts the latest precision oncology innovations within reach for all cancer care organizations. By providing accessible and affordable biomarker solutions, data-driven insights, and clinical validation services, we are a true partner in transforming cancer care.

 

Imagia Canexia Health has purpose-built assays and software solutions to help address cancer treatment disparities. As a result of our recent merger, we are expanding our footprint globally to enable expanded access to precision-guided cancer management. 

 

Imagia Canexia Health is leading the use of AI in building precision oncology software 

We’re leading a group of five established institutions: BC Cancer Research, DNAstack, Microsoft, Queen’s University and University Health Network as part of the $17.8M CanDETECT project. 

Our Liquid Biopsy solution, Follow ItⓇ, has been named as one of CADTH’s top 10 health technologies to watch. Learn more about us under companion diagnostics alongside other impactful health tech advances. 

 

 

Your partner in accelerating equitable access to precision oncology. 

Let’s connect at ASCO.